| Dr Victor Orosco Macias, MD | |
|
2500 Ne Neff Rd, Bend, OR 97701-6015 | |
| (541) 706-6892 | |
| (541) 706-6813 |
| Full Name | Dr Victor Orosco Macias |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 31 Years |
| Location | 2500 Ne Neff Rd, Bend, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093095929 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD60744325 (Washington) | Secondary |
| 208M00000X | Hospitalist | ME 124892. (Florida) | Secondary |
| 207Q00000X | Family Medicine | MD157560 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Orlando Health | Orlando, FL | Hospital |
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Orlando Health South Lake Hospital | Clermont, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Charles Health System Inc | 3870402852 | 150 |
| Orlando Health Medical Group Inc | 9537059084 | 1417 |
News Archive
Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.
LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has entered into three new master services agreements with some of the most important global sponsors for each of the pharmaceutical, biotechnology and agro-chemical industries.
› Verified 1 days ago
| Entity Name | Legacy Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902827272 PECOS PAC ID: 0244144004 Enrollment ID: O20031117000089 |
News Archive
Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.
LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has entered into three new master services agreements with some of the most important global sponsors for each of the pharmaceutical, biotechnology and agro-chemical industries.
› Verified 1 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982774378 PECOS PAC ID: 4587573001 Enrollment ID: O20031215000598 |
News Archive
Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.
LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has entered into three new master services agreements with some of the most important global sponsors for each of the pharmaceutical, biotechnology and agro-chemical industries.
› Verified 1 days ago
| Entity Name | St Charles Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982621447 PECOS PAC ID: 3870402852 Enrollment ID: O20040112000045 |
News Archive
Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.
LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has entered into three new master services agreements with some of the most important global sponsors for each of the pharmaceutical, biotechnology and agro-chemical industries.
› Verified 1 days ago
| Entity Name | Silverton Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669424354 PECOS PAC ID: 8921901877 Enrollment ID: O20040129000172 |
News Archive
Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.
LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has entered into three new master services agreements with some of the most important global sponsors for each of the pharmaceutical, biotechnology and agro-chemical industries.
› Verified 1 days ago
| Entity Name | Albany General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154372340 PECOS PAC ID: 9931097987 Enrollment ID: O20040310000310 |
News Archive
Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.
LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has entered into three new master services agreements with some of the most important global sponsors for each of the pharmaceutical, biotechnology and agro-chemical industries.
› Verified 1 days ago
| Entity Name | South Sound Inpatient Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508023789 PECOS PAC ID: 5991618738 Enrollment ID: O20050401000747 |
News Archive
Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.
LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has entered into three new master services agreements with some of the most important global sponsors for each of the pharmaceutical, biotechnology and agro-chemical industries.
› Verified 1 days ago
| Entity Name | Asante Physician Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922381326 PECOS PAC ID: 8325206246 Enrollment ID: O20120223000671 |
News Archive
Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.
LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has entered into three new master services agreements with some of the most important global sponsors for each of the pharmaceutical, biotechnology and agro-chemical industries.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victor Orosco Macias, MD Po Box 6095, Bend, OR 97708-6095 Ph: (541) 706-5922 | Dr Victor Orosco Macias, MD 2500 Ne Neff Rd, Bend, OR 97701-6015 Ph: (541) 706-6892 |
News Archive
Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).
Emmanuel Njeuhmeli, a senior biomedical prevention advisor in the USAID Office of HIV/AIDS, discusses efforts to raise awareness about male circumcision as a "cost saving and effective form of HIV prevention" in a post on USAID's "Impact Blog."
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.
LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has entered into three new master services agreements with some of the most important global sponsors for each of the pharmaceutical, biotechnology and agro-chemical industries.
› Verified 1 days ago
Wendy Yerington Dryden, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2577 Ne Courtney Dr Ste 100, Bend, OR 97701 Phone: 541-383-3005 Fax: 541-383-1883 | |
Lisa Kristine Mizeur, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 2600 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-4800 Fax: 541-706-4806 | |
William B Wignall, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1247 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-318-4249 | |
Edward M Tarbet, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1501 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-2811 Fax: 541-317-4588 | |
Michael R. Hudson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2600 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-3700 Fax: 541-706-3730 | |
Dr. Michelle Ann Kyriakos, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1375 Nw Kingston Ave, Bend, OR 97701 Phone: 541-383-5958 Fax: 541-383-3016 | |
Dr. Laura Kay Pennavaria, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 568 Ne Savannah Dr, Bend, OR 97701 Phone: 541-516-1705 Fax: 541-833-2619 |